Fingolimod in Preventing Paclitaxel-Associated Neuropathy in Patients With Breast Cancer

Summary

This trial phase I studies how well fingolimod works in preventing chemotherapy-induced nerve pain (neuropathy) in patients with breast cancer who are taking paclitaxel. Fingolimod acts by suppressing immune reactions in the brain. This study is being done to see if fingolimod can reduce neuropathy caused by paclitaxel.

Timeline

Start

2019-12-12

Primary completion

2020-06-05

Completion

2021-11-23

Drugs

Indications